Calendar Sagimet Biosciences Inc.

Equities

SGMT

US7867001049

End-of-day quote Nasdaq 06:00:00 2024-05-14 pm EDT 5-day change 1st Jan Change
4.62 USD +5.48% Intraday chart for Sagimet Biosciences Inc. +4.05% -14.76%

Chart calendar Sagimet Biosciences Inc.

a7475c45676336455144cf52f2c.evBJOmeMPq9mgadAm6sbZPvXej7KOIz1dEaP1COx1OY.EoMwcATkeMtU0-wi6O4tDo-mEAeDbL6ZAhThrGjClYwXvhBtX8ZrwijmxA~4e3c46525648eac14e6c0279144231b8

Upcoming events on Sagimet Biosciences Inc.

2024-06-05 01:00 pm Annual General Meeting
2024-06-06 06:15 am EASL International Liver Congress
2024-08-18 Q2 2024 Earnings Release (Projected)
2024-11-10 Q3 2024 Earnings Release (Projected)
2025-03-30 Q4 2024 Earnings Release (Projected)
2025-05-13 Q1 2025 Earnings Release (Projected)

Past events on Sagimet Biosciences Inc.

2024-05-15 08:00 am Q1 2024 Earnings Release
2024-05-03 12:30 pm Investor and Analyst Day
2024-03-25 06:15 am Q4 2023 Earnings Release
2024-03-13 08:00 am Leerink Partners Global Biopharma Conference
2024-03-05 02:10 pm TD Cowen Health Care Conference
2024-01-22 08:00 am FASCINATE-2 Phase 2b Clinical Trial Results Call
2023-12-06 12:00 pm Goldman Sachs Catalyst Clinic Conference
2023-11-29 03:30 pm Piper Sandler Healthcare Conference
2023-11-28 12:30 pm Obesity and NASH Drug Development Summit
2023-11-13 08:00 am Q3 2023 Earnings Release
2023-11-11 01:00 pm American Association for the Study of Liver Diseases Conference
2023-11-09 American Association for the Study of Liver Diseases Conference
2023-10-24 03:00 pm H.C. Wainwright NASH Investor Conference
2023-08-21 04:02 pm Q2 2023 Earnings Release

Annual results

Fiscal PeriodDecember 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00


2,00
2,00
0%

0,00

EBITDA
Released
Forecast
Spread
0,00


0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
0,00


-30,7
-33,1
7.04%

-59,3

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


-27,9
-31,1
10.32%

-61,1

Net income
Million USD
Released
Forecast
Spread
-30,5


-27,9
-31,1
10.32%

-61,1

EPS
USD
Released
Forecast
Spread
-165


-2,66
-3,19
16.61%

-2,06

Announcement Date24/03/2325/03/24-

Quarterly results

Fiscal PeriodDecember 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
2,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread
-7,06
-8,70
18.89%
-7,45
-10,2
26.65%
-9,47
-11,8
19.69%
-8,77
-10,7
17.87%

-11,0


-14,4


-21,8


-27,2

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-6,79
-7,40
8.31%
-6,35
-9,35
32.02%
-8,15
-11,4
28.33%
-6,63
-10,4
36.01%

-11,5


-16,5


-26,4


-27,2

Net income
Million USD
Released
Forecast
Spread
-6,79
-7,50
9.53%
-6,35
-9,40
32.38%
-8,15
-11,4
28.64%
-6,63
-10,4
36.38%

-11,5


-16,5


-26,4


-27,2

EPS
USD
Released
Forecast
Spread
-35,8
-0,44
-8036.36%
-0,35
-1,02
65.52%

-0,53

-0,23
-0,41
43.9%

-0,39


-0,55


-0,88


-0,93

Announcement Date21/08/2313/11/2325/03/2415/05/24----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. SGMT Stock
  4. Calendar Sagimet Biosciences Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW